StockData
Equillium, Inc. logo

Equillium, Inc. (EQ) stock

EQNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 8/30
$1.15−0.14 (-10.85%)

Close on Nov 16, 2026Market cap $72.92MP/E –Yield –

Equillium total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Equillium's total debt was $7.56M at Mar 31, 2023. For fiscal 2022 it was $8.95M, down 12.0% from the year before.

Annual total debt

PeriodPeriod endValueChange
FY2022Dec 31, 2022$8.95M-12.0%
FY2021Dec 31, 2021$10.18M+2.4%
FY2020Dec 31, 2020$9.94M+2.7%
FY2019Dec 31, 2019$9.68M–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q1 FY2023Mar 31, 2023$7.56M-26.1%
Q4 FY2022Dec 31, 2022$8.95M-12.0%
Q3 FY2022Sep 30, 2022$10.33M+2.0%
Q2 FY2022Jun 30, 2022$10.28M+2.1%
Q1 FY2022Mar 31, 2022$10.23M+2.2%
Q4 FY2021Dec 31, 2021$10.18M+2.4%
Q3 FY2021Sep 30, 2021$10.12M+2.5%
Q2 FY2021Jun 30, 2021$10.07M+2.6%
Q1 FY2021Mar 31, 2021$10.01M+2.7%
Q4 FY2020Dec 31, 2020$9.94M+2.7%
Q3 FY2020Sep 30, 2020$9.88M+2.7%
Q2 FY2020Jun 30, 2020$9.81M–
Q1 FY2020Mar 31, 2020$9.75M–
Q4 FY2019Dec 31, 2019$9.68M–
Q3 FY2019Sep 30, 2019$9.62M–

More Equillium figures

See a number that looks wrong?